Sun Pharmaceutical Industries Limited

NSE:SUNPHARMA.NS

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

💊 Drugstores & Retail Pharmacies

Location

India

Market Cap

USD 46.12 B

Share Price

USD 19.22

Avg Daily Volume

2,720,780

Change (1 day)

1.16%

Change (1 year)

9.32%

Change (YTD)

-12.78%

Sun Pharmaceutical Industries Limited Revenue Year-on-Year (YoY) growth for the year ending March 31, 2025: 7.46%

Sun Pharmaceutical Industries Limited Revenue Year-on-Year (YoY) growth is 7.46% for the year ending March 31, 2025. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period. Year-on-Year (YoY) growth is the change in a financial metric compared to the same period in the previous year, expressed as a percentage.

Sun Pharmaceutical Industries Limited Revenue for the year ending March 31, 2024 was USD 5.73 B, a 8.74% change year over year.
Sun Pharmaceutical Industries Limited Revenue for the year ending March 31, 2024 was USD 5.73 B, a 0.00% change year over year.
Sun Pharmaceutical Industries Limited Revenue for the year ending March 31, 2023 was USD 5.27 B, a 4.05% change year over year.
Sun Pharmaceutical Industries Limited Revenue for the year ending March 31, 2022 was USD 5.06 B, a 11.82% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Revenue Year-on-Year (YoY) growth	Gross Profit	Operating Income	EBIT

NSE: SUNPHARMA.NS

Sun Pharmaceutical Industries Limited

CEO	Mr. Abhay Gandhi
IPO Date	Jan. 1, 1996
Location	India
Headquarters	Sun House
Employees	43,000
Sector	🏥 Health Care
Industries Pharmaceuticals 💊 Drugstores & Retail Pharmacies

Description

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances; generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.